LUPIN LTD share price has Zoomed 5% and is presently trading at Rs 785.
Meanwhile, the BSE HEALTHCARE Index is at 13,354 (Up 2.3%).
Among the top Gainers in the BSE HEALTHCARE Index today are LUPIN LTD (up 5.04%) and SUN PHARMA (up 7.08%).
SHILPA MEDICARE (down 0.02%) and SANOFI INDIA (down 0.30%) are among the top losers today.
Over the last one year, LUPIN LTD has moved down from Rs 1,138 to Rs 785, registering a loss of Rs 353 (down 31.05%)
On the other hand, the BSE HEALTHCARE has moved down from 13,695 to 13,354, loss of 341 points (down 2.59%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were BIOCON LTD (up 114.88%), DIVIS LABORATORIES (up 100.62%) and ABBOTT INDIA (up 64.67%).
What About the Benchmark Indices?
The BSE Sensex is at 35,216 (up 0.74%).
The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 7.08%), GAIL (up 4.24%) and BHEL (up 3.73%). Other gainers include COAL INDIA (up 3.57%) and MARUTI SUZUKI (up 2.53%). The most traded stocks in the BSE Sensex are RELIANCE IND. and SUN PHARMA.
In the meantime, NSE Nifty is at 10,702 (up 0.83%). SUN PHARMA (up 7.17%) and LUPIN LTD (up 5.26%) are among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 30,750 to 35,216, registering a gain of 4,466 points (up 14.41%).
LUPIN LTD Financial Update...
LUPIN LTD net profit declined 353.9% YoY to Rs 8 billion for the quarter ended March 2018, compared to a loss of Rs 2 billion a year ago. Net Sales rose 101.5% to Rs 40.3 billion during the period as against Rs 39.8 billion in January-March 2017.
For the year ended March 2017, LUPIN LTD reported 112.9% increase in net profit to Rs 25.6 billion compared to net profit of Rs 22.6 billion during FY16.
Revenue of the company grew 122.7% to Rs 175 billion during FY17.
The current Price to earnings ratio of LUPIN LTD, based on rolling 12 month earnings, stands at 141.1x.
This article was originally published in English at www.equitymaster.com
Read the complete Indian stock market update. For the terms of use, go here.
No comments:
Post a Comment